BiotechTube
Home/Stereotaxis/Kimberly R. Peery
KR

Kimberly R. Peery

Chief Financial Officer

Stereotaxis

Therapeutic Areas

CardiovascularCardiac Arrhythmias

Stereotaxis Pipeline

DrugIndicationPhase
Genesis RMN SystemCardiac Ablation for Arrhythmias (AFib, VT)Commercial
Magnetically-Enabled Ablation CatheterCardiac AblationDevelopment/Regulatory Review
Odyssey Software EcosystemProcedural Integration & VisualizationCommercial & Development

Leadership Team at Stereotaxis

DF
David Fischel
Chairman and Chief Executive Officer
DH
David H. Kim
Chief Technology Officer (Eindhoven-based)
View full Stereotaxis profile